Just Released: "Bronchitis Therapeutics - Pipeline Assessment and Market Forecasts to 2018"

April 15, 2012 - PRLog -- Bronchitis Therapeutics - Pipeline Assessment and Market Forecasts to 2018

Summary

GlobalData, the industry analysis specialist, has released its new report, "Bronchitis Therapeutics - Pipeline Assessment and Market Forecasts to 2018". The report is an essential source of information and analysis on the global Bronchitis Therapeutics market. The report identifies the key trends shaping and driving the global Bronchitis Therapeutics market. The report also provides insights on the prevalent competitive landscape and the emerging players expected to significantly alter the market positioning of the current market leaders. Most importantly, the report provides valuable insights on the pipeline products within the global Bronchitis Therapeutics sector. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

------------------------------------------------------------
Full Report Details at
- http://www.fastmr.com/prod/320381_bronchitis_therapeutics...
------------------------------------------------------------

Scope

The report provides information on the key drivers and challenges of the Bronchitis Therapeutics market. Its scope includes -

* Annualized seven key markets (US, France, Germany, Italy, Spain, UK and Japan) Bronchitis Therapeutics market revenues data from 2005 to 2009, forecast for eight years to 2018.
* Pipeline analysis data providing a split across the different phases, mechanisms of action being developed and emerging trends by seven key markets. Pipeline candidates fall under major therapeutic classes.
* Analysis of the current and future competition in the seven key countries Bronchitis Therapeutics market.
* Insightful review of the key industry drivers, restraints and challenges. Each trend is independently researched to provide a qualitative analysis of its implications.
* Key topics covered include strategic competitor assessment, market characterization, unmet needs and the implications for the Bronchitis Therapeutics market.
* Analysis of key recent licensing and partnership agreements in Bronchitis Therapeutics market

Reasons to buy

The report will enhance your decision making capability. It will allow you to -

* Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies and by identifying the companies with the most robust pipeline.
* Develop business strategies by understanding the trends shaping and driving the global Bronchitis Therapeutics market.
* Drive revenues by understanding the key trends, innovative products and technologies, market segments and companies likely to impact the global Bronchitis Therapeutics market in future.
* Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various competitors.
* Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
* Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.
* What's the next big thing in the global Bronchitis Therapeutics market landscape? - Identify, understand and capitalize.

Companies Mentioned in this Report: GlaxoSmithKline, Novartis AG, AstraZeneca, Bronchitis Pipeline, Merck & Co., Forest Laboratories, Inc., Boehringer Ingelheim GmbH, Financial Overview, Almirall, S.A., Orion Corporation, Rottapharm Madaus, Ache Laboratorios Farmaceuticos S/A

Partial Table of Contents:

1 Table of Contents
1 Table of Contents
1.1 List of Tables
1.2 List of Figures
2 Bronchitis Therapeutics - Introduction
2.1 Disease Overview
2.1.1 Forms of Bronchitis -
2.2 Epidemiology
2.3 Etiology and Pathophysiology
2.4 Risk factors for Bronchitis
2.5 Signs and Symptoms
2.6 Prognosis:
2.7 Diagnosis
2.8 Referral Pathway
2.9 Treatment and Management Pattern
2.10 GlobalData Pipeline Report Guidance
3 Bronchitis Therapeutics - Market Characterization
3.1 Overview
3.2 Bronchitis Therapeutics Market Size (2005 - 2010) - Global
3.3 Bronchitis Therapeutics Market Forecast (2010 - 2018) - Global
3.4 Bronchitis Therapeutics Market Size (2005 - 2010) - The US
3.5 Bronchitis Therapeutics Market Forecast (2010 - 2018) - The US
3.6 Bronchitis Therapeutics Market Size (2005 - 2010) - France
3.7 Bronchitis Therapeutics Market Forecast (2010 - 2018) - France
3.8 Bronchitis Therapeutics Market Size (2005 - 2010) - Germany
3.9 Bronchitis Therapeutics Market Forecast (2010-2018) - Germany
3.10 Bronchitis Therapeutics Market Size (2005 - 2010) - Italy
3.11 Bronchitis Therapeutics Market Forecast (2010 - 2018) - Italy
3.12 Bronchitis Therapeutics Market Size (2005 - 2010) - Spain
3.13 Bronchitis Therapeutics Market Forecast (2010 - 2018) - Spain
3.14 Bronchitis Therapeutics Market Size (2005 - 2010) - The UK
3.15 Bronchitis Therapeutics Market Forecast (2010 - 2018) - The UK
3.16 Bronchitis Therapeutics Market Size (2005 - 2010) - Japan
3.17 Bronchitis Therapeutics Market Forecast (2010 - 2018) - Japan
3.18 Drivers and Barriers for the Bronchitis Therapeutics Market
3.18.1 Drivers for the Bronchitis Therapeutics Market
3.18.2 Barriers for the Bronchitis Therapeutics Market
3.19 Opportunity and Unmet Need Analysis
3.19.1 Opportunity and Unmet Need in the Bronchitis Therapeutics Market
3.20 Key Takeaway
4 Bronchitis Therapeutics - Competitive Assessment
4.1 Overview
4.2 Strategic Competitor Assessment
4.3 Product Profile for the Major Marketed Products in the Bronchitis Therapeutics Market
4.3.1 Spiriva HandiHaler (tiotropium bromide inhalation powder)
4.3.2 Foradil Aerolizer (formoterol fumarate inhalation powder)
4.3.3 Symbicort (budesonide/formoterol fumarate dihydrate) 160/4.5ug

Full Table of Contents is available at:
-- http://www.fastmr.com/catalog/product.aspx?productid=3203...

About GlobalData

GlobalData is a leading provider of global business intelligence including market, competitor, product and customer information. It provides in-depth research, analysis, data and forecasts through a range of interactive online databases, reports and management briefings. GlobalData has a large team of experienced research and analysis, consulting, and marketing experts. It has a global presence, including key offices in the US, Europe and Asia. The group has over 50 years of experience of delivering market intelligence data and analysis and a highly experienced senior management team.  View more research from GlobalData at http://www.fastmr.com/catalog/publishers.aspx?pubid=1015

# # #

Fast Market Research is an online aggregator and distributor of market research and business information. We represent the world's top research publishers and analysts and provide quick and easy access to the best competitive intelligence available.